Rhoen Klinikum AG (WBO:RHK) Market Cap: €937 Mil (As of Jul. 08, 2026)


WBO:RHK Rhoen Klinikum AG WBO:RHK
74 GF Score
Price €14.10
GF Value €13.69
! 5 Warning Signs
View Full Analysis

What is Rhoen Klinikum AG Market Cap?

Rhoen Klinikum AG WBO:RHK +1.44% 74 Market Cap is €937 Mil as of Jul. 08, 2026. GuruFocus rates WBO:RHK with a GF Score™ of 74/100 and a GF Value™ of €13.69. The stock has 5 warning signs investors should review. Among 692 Healthcare Providers & Services companies, Rhoen Klinikum AG ranks better than 80.49% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Rhoen Klinikum AG's share price for the quarter that ended in Mar. 2026 was €12.4. Rhoen Klinikum AG's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 67 Mil. Therefore, Rhoen Klinikum AG's market cap for the quarter that ended in Mar. 2026 was €830 Mil.

Rhoen Klinikum AG's quarterly market cap increased from Sep. 2025 (€776 Mil) to Dec. 2025 (€864 Mil) but then declined from Dec. 2025 (€864 Mil) to Mar. 2026 (€830 Mil).

Rhoen Klinikum AG's annual market cap increased from Dec. 2023 (€676 Mil) to Dec. 2024 (€930 Mil) but then declined from Dec. 2024 (€930 Mil) to Dec. 2025 (€864 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Rhoen Klinikum AG's Enterprise Value for Today is €748 Mil.


Rhoen Klinikum AG  (WBO:RHK) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Rhoen Klinikum AG Market Cap Related Terms


Rhoen Klinikum AG Market Cap Historical Data

* Premium members only.

The historical data trend for Rhoen Klinikum AG's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rhoen Klinikum AG Market Cap Chart

Rhoen Klinikum AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 959.89 1,034.19 676.07 930.44 863.50

Rhoen Klinikum AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 890.28 803.26 776.48 863.50 830.03

WBO:RHK vs HCA, THC, DVA: Market Cap Comparison

For the Medical Care Facilities subindustry, Rhoen Klinikum AG's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rhoen Klinikum AG Market Cap vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Rhoen Klinikum AG's Market Cap distribution charts can be found below:

* The bar in red indicates where Rhoen Klinikum AG's Market Cap falls into.


WBO:RHK
74GF Score
Rhoen Klinikum AG WBO:RHK
Market Cap is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rhoen Klinikum AG Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Rhoen Klinikum AG's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as

Market Cap (A: Dec. 2025 )=Share Price (A: Dec. 2025 )*Shares Outstanding (EOP) (A: Dec. 2025 )
=€12.9*66.938
=€864

Rhoen Klinikum AG's Market Cap for the quarter that ended in Mar. 2026 is calculated as

Market Cap (Q: Mar. 2026 )=Share Price (Q: Mar. 2026 )*Shares Outstanding (EOP) (Q: Mar. 2026 )
=€12.4*66.938
=€830

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of €937 Mil mean?
Rhoen Klinikum AG (WBO:RHK) has a Market Cap of €937 Mil as of Jul. 08, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Rhoen Klinikum AG and its competitors. According to the industry distribution chart, Rhoen Klinikum AG ranks #135 out of 692 companies in the Healthcare Providers & Services industry, placing it in the top 19.5%.
Is Rhoen Klinikum AG's Market Cap too high?
Rhoen Klinikum AG's current Market Cap is €937 Mil. Based on the distribution chart, Rhoen Klinikum AG ranks #135 out of 692 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Rhoen Klinikum AG has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Rhoen Klinikum AG's Market Cap compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Rhoen Klinikum AG ranks #135 out of 692 companies for Market Cap. This places Rhoen Klinikum AG in the top 20% of its industry — outperforming the majority of peers. The industry median Market Cap is 98.72. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 98.72, based on 692 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Rhoen Klinikum AG and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 98.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rhoen Klinikum AG's current Market Cap is €937 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rhoen Klinikum AG stock overvalued right now?
Rhoen Klinikum AG (WBO:RHK) has a current Market Cap of €937 Mil. The stock's GF Value™ is €13.69, compared to a current price of €14.10 — trading 3% above its estimated fair value. The current Market Cap is €937 Mil. Rhoen Klinikum AG's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Rhoen Klinikum AG (WBO:RHK), the current Market Cap is €937 Mil as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rhoen Klinikum AG (WBO:RHK) Overvalued in 2026?

Based on GuruFocus' analysis, Rhoen Klinikum AG stock appears to be overvalued. The current stock price of €14.10 is trading 3% above its estimated GF Value™ of €13.69.

Key valuation signals for WBO:RHK:

  • Market Cap: €937 Mil
  • GF Value™: €13.69 vs. price of €14.10 (3% above fair value)
  • GF Score™: 74/100 with 5 warning signs

No single metric tells the full story. See the WBO:RHK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Rhoen Klinikum AG Business Description

Other Exchanges 0NQH:UKRHK:Germany
Address Salzburger Leite 1, Bad Neustadt a. d. Saale, DEU, 97616
Rhoen Klinikum AG provides medical care and healthcare services. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on inpatient, semi-inpatient and outpatient healthcare basis. The company generates the entire revenue in Germany, with the Bavaria and Hesse regions contributing the majority proportions of revenue.
74GF Score

Get the complete analysis for WBO:RHK

Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€14.10
Price
€13.69
GF Value